Urogenital Diseases

2

Review clinical trials related to Urogenital Diseases. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma

This is a multicenter real world study (RWS) initiated by the investigator. Eligible patients will be selected for treatment with second-line treatment including vorolanib and followed up. The real survival data of patients after medication will be collected and compared with the data of CONCEPT study, and multi-factor stratified analysis of the efficacy of voronib will be conducted.

Participants needed: 39
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Jinling Hospital, ChinaUpdated: Dec 5, 2025Locations: 1Duration: 12 Weeks
Eligibility criteria

Subjects have fully understood and voluntarily signed the informed consent form... [+4]

A history of malignancies other than the disease studied within the past 5 years... [+15]

Status: Recruiting

Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab

This is a non-blinded phase 2 trial in Stage II-IIIa urothelial cancer randomizing pre-operative nivolumab with or without relatlimab to assess whether bladder preservation after dual immunotherapy would be a viable treatment option for patients responding to treatment

Participants needed: 90
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: The Netherlands Cancer InstituteUpdated: Sep 3, 2025Locations: 9
Eligibility criteria

Willing and able to provide informed consent [+10]

Subjects with active autoimmune disease in the past 2 years. Patients with diabe... [+16]